Literature DB >> 19718053

p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.

Y-C Chang1, S-C Tien, H-F Tien, H Zhang, G M Bokoch, Z-F Chang.   

Abstract

Chronic myeloid leukemia (CML) is a lethal hematological disorder caused by the p210(Bcr-Abl) oncogene. Previous studies have suggested that p210(Bcr-Abl) transformation contributes to homing and retention defects, typical of immature myeloid cells in CML, by attenuating chemotactic response to stromal-derived factor-1alpha (SDF-1alpha). As Rho family GTPases are key regulators of the cytoskeleton and have been previously found to interact with p210(Bcr-Abl), this study aimed to determine whether p210(Bcr-Abl) signaling affects SDF-1alpha chemotaxis through Rho GTPase signaling. We found that SDF-1alpha stimulated Cdc42 GTPase activation in myeloid progenitor 32D, but not in p210(Bcr-Abl)-transformed (32Dp210) cells. In fact, the basal level of active Cdc42 was elevated in 32Dp210 cells and mononuclear cells isolated from bone marrow of CML patients. Inhibition of p210(Bcr-Abl) kinase activity decreased basal Cdc42 activity and restored SDF-1alpha-induced Cdc42 and migration responses. Transduction of active Tat-Cdc42V12 abolished this reconstituted chemotactic response. As Cdc42 is particularly important in cytoskeletal remodeling and directional sensing, these results suggest that sustained activation of Cdc42 GTPase through p210(Bcr-Abl) tyrosine kinase signaling in CML cells contributes to defects in SDF-1alpha-chemotactic response due to desensitization of the actin polarization signal required for directional migration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19718053     DOI: 10.1038/onc.2009.260

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

Review 1.  Are Molecules Involved in Neuritogenesis and Axon Guidance Related to Autism Pathogenesis?

Authors:  Jan Bakos; Zuzana Bacova; Stephen G Grant; Ana M Castejon; Daniela Ostatnikova
Journal:  Neuromolecular Med       Date:  2015-05-20       Impact factor: 3.843

Review 2.  The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.

Authors:  Erica Dander; Chiara Palmi; Giovanna D'Amico; Giovanni Cazzaniga
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

3.  miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML).

Authors:  Jia Fei; Yumin Li; Xuejiao Zhu; Xiaochuang Luo
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

4.  Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.

Authors:  Chung-Yu Ku; Yu-Huei Liu; Hsuan-Yuan Lin; Shao-Chun Lu; Jung-Yaw Lin
Journal:  Oncotarget       Date:  2016-04-05

5.  RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.

Authors:  Chunming Gu; Maoxiao Feng; Zhao Yin; Xiaochuang Luo; Juhua Yang; Yumin Li; Tianfu Li; Ruirui Wang; Jia Fei
Journal:  Oncotarget       Date:  2016-04-12

Review 6.  Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.

Authors:  Naofumi Mukaida; Yamato Tanabe; Tomohisa Baba
Journal:  Int J Mol Sci       Date:  2017-08-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.